✦ LIBER ✦

The ErbB3 binding protein EBP1 regulates ErbB2 protein levels and tamoxifen sensitivity in breast cancer cells

✍ Scribed by Yan Lu; Hua Zhou; Wantao Chen; Yuexing Zhang; Anne W. Hamburger

Publisher: Springer US
Year: 2010
Tongue: English
Weight: 461 KB
Volume: 126
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-010-0873-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ectopic expression of the ErbB-3 binding

Ectopic expression of the ErbB-3 binding protein Ebp1 inhibits growth and induces differentiation of human breast cancer cell lines

✍ Tracy J. Lessor; Joo-Yeon Yoo; Xianmin Xia; Nicholas Woodford; Anne W. Hamburger 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 2 views

Ebp1, an ErbB-3 binding protein, translocates from the cytoplasm to the nucleus of human breast cancer cells after treatment with the ErbB-3 ligand, heregulin. The purpose of these studies was to examine the effects of ectopic expression of ebp1 on the biological properties of human ErbB-3-expressin

Effects of the combined blockade of EGFR

Effects of the combined blockade of EGFR and ErbB-2 on signal transduction and regulation of cell cycle regulatory proteins in breast cancer cells

✍ Amelia D’Alessio; Antonella De Luca; Monica R. Maiello; Luana Lamura; Anna Maria 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 584 KB

CCAAT/enhancer binding protein δ (C/EBPδ

CCAAT/enhancer binding protein δ (C/EBPδ) regulation and expression in human mammary epithelial cells: I. “Loss of function” alterations in the C/EBPδ growth inhibitory pathway in breast cancer cell lines

✍ G.S. Sivko; J.W. DeWille 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 1 views

## Abstract “Loss of function” alterations in growth inhibitory signal transduction pathways are common in cancer cells. In this study, we show that growth arrest (GA) treatments—serum and growth factor withdrawal and growth inhibitory IL‐6 family cytokines (Interleukin‐6 and Oncostatin M (OSM))—in

High cell kinetics is associated with am

High cell kinetics is associated with amplification of the int-2, bcl-1, myc and erbB-2 proto-oncogenes and loss of heterozygosity at the DF3 locus in primary breast cancers

✍ Alma Contegiacomo; Claudia Pizzi; Laura De Marchis; Maurizio Alimandi; Paolo Del 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 773 KB

Cell kinetics, is a predictive parameter of breast-cancer aggressiveness, and mutations occurring in mammary tumorigenesis may favor iuncontrolled cell proliferation. In this study, cell kinetics, clinico-pathological characteristics and genetic alterations at the irrt-2, bcl-I, c-myc, c-erbB-2, and

The expression of insulin-like growth fa

The expression of insulin-like growth factor and its binding protein mRNA in the endometrium of postmenopausal patients with breast cancer receiving tamoxifen

✍ Timo J. Laatikainen; Eija I. Tomás; Raimo J. Voutilainen 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB 👁 2 views

Differential insulin-like growth factor

Differential insulin-like growth factor (IGF)-independent interactions of IGF binding protein-3 and IGF binding protein-5 on apoptosis in human breast cancer cells. Involvement of the mitochondria.

✍ C. M. Perks; C. McCaig; J. M. P. Holly 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 324 KB 👁 2 views